With generic versions of the weight-loss drug Ozempic expected to hit the Canadian market this year, provincial data shows ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

People who stop taking anti-obesity drugs will within two years return to their original weight and forfeit benefits to the ...

Amid a rise in obesity and Type 2 diabetes citywide, Maimonides Health celebrated the one-year anniversary of its Weight ...

Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By extending ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exercise, says chair of global public health at the University of Edinburgh, Prof De ...

GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...

People who use weight-loss drugs can rapidly regain weight after stopping treatment, according to a new studyView on euronews ...

Last month, Novo Nordisk won Food and Drug Administration approval for the first GLP-1 pill for weight loss. The medication, ...

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce ...